Neuralink secures $650M Series E funding to fast-track AI brain chip tech and FDA trials. See which investors are backing Elon Musk’s bold vision.
Matilda
Neuralink Raises $650M for Brain Chip Expansion Neuralink Raises $650M Series E to Accelerate AI Brain Chips Wondering how far Elon Musk's Neuralink has come with its futuristic brain chip technology? Neuralink is back in headlines after securing $650 million in Series E funding , reaffirming investor confidence in the rapidly evolving brain-computer interface (BCI) sector. With prominent backers like ARK Invest, Founders Fund, Sequoia Capital, and Thrive Capital joining the round, this funding milestone signals a major leap forward for AI-powered neural implants—technology that could redefine treatment options for neurological disorders , paralysis , and beyond. Breakthrough Device Status and Human Trials Drive Momentum This massive funding round follows Neuralink’s impressive progress in human clinical trials . Since its $280 million Series D in 2023 (and a subsequent $43 million top-up), the company has successfully implanted brain chips into five individuals suffering from severe paralysis . These implants are being evaluated as po…